194 related articles for article (PubMed ID: 11011811)
1. Antithrombotics and anticoagulants in coronary syndromes and stroke.
Turpie AG
Semin Thromb Hemost; 2000; 26 Suppl 1():79-83. PubMed ID: 11011811
[TBL] [Abstract][Full Text] [Related]
2. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
Ottani F; Ferrini D; Di Pasquale G; Galvani M
Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
[TBL] [Abstract][Full Text] [Related]
3. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
Mukherjee D; Eagle KA
Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
[TBL] [Abstract][Full Text] [Related]
4. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
5. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
Nicolau JC; Cohen M; Montalescot G
J Cardiovasc Pharmacol; 2009 Jun; 53(6):440-5. PubMed ID: 19365279
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of low-molecular-weight heparin in cardiovascular medicine.
Hirsh J; Bates SM
Prog Cardiovasc Dis; 2000; 42(4):235-46. PubMed ID: 10661777
[TBL] [Abstract][Full Text] [Related]
7. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
González Pacheco H
Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparins and glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
Ferguson J
J Invasive Cardiol; 2004 Mar; 16(3):136-44. PubMed ID: 15152164
[TBL] [Abstract][Full Text] [Related]
9. Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.
Moser LR; Kalus JS
Ann Pharmacother; 2004 Dec; 38(12):2094-104. PubMed ID: 15536140
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparins in the treatment of unstable angina.
Ageno W; Turpie AG
Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
Spinler SA; Inverso SM; Cohen M; Goodman SG; Stringer KA; Antman EM;
Am Heart J; 2003 Jul; 146(1):33-41. PubMed ID: 12851605
[TBL] [Abstract][Full Text] [Related]
13. [Role of low-molecular-weight heparin in acute coronary syndromes].
Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
[TBL] [Abstract][Full Text] [Related]
14. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy in acute coronary syndromes: key notes from ESSENCE and TIMI 11B.
Fox KA
Semin Hematol; 2001 Apr; 38(2 Suppl 5):67-74. PubMed ID: 11449345
[TBL] [Abstract][Full Text] [Related]
16. [The assessment of safety of enoxaparin administration during percutaneous transluminal coronary angioplasty after ticlopidine pretreatment. Application of low molecular weigh heparins in prevention of coronary micro-embolization].
Dudek D; Zymek P; Bartuś S; Dubiel JS
Przegl Lek; 2001; 58(6):484-6. PubMed ID: 11816736
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of low molecular weight heparins in acute coronary syndromes: an interventionalist's perspective.
Gulba D
Semin Thromb Hemost; 1999; 25 Suppl 3():123-7. PubMed ID: 10549727
[TBL] [Abstract][Full Text] [Related]
18. The use of antithrombotic drugs in older people.
Tufano A; Cerbone AM; Di Minno G
Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism after ischemic stroke.
Kase CS; Pineo GF
Curr Opin Pulm Med; 2008 Sep; 14(5):389-96. PubMed ID: 18664967
[TBL] [Abstract][Full Text] [Related]
20. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
Husted S; Kher A
Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
